AbstractIn order to determine the prognostic impact of lymphovascular invasion (LVI) in patients after radical prostatectomy, the retrospective data from our institution has been analyzed. From 1998 to 2010, 117 patients underwent radical prostatectomy. A total of 87 patients were included in this retrospective study. The relationship between LVI and advanced prostate cancer characteristics was evaluated by χ2 test. The Kaplan-Meier method and meta-analysis were used to describe the impact of LVI invasion upon early biochemical failure after radical prostatectomy. LVI was observed in patients with clinically or pathologically aggressive prostate cancer including patients of higher preoperative risk group, higher preoperative PSA, advanced G...
Aim To determine the impact of the extent of lymph node invasion (LNI) on long-term oncological out...
This paper, based on the activity of the Morphology-Based Prognostic Factors Committee of the 2004 W...
BACKGROUND: Bladder cancer is the fourth most frequently diagnosed cancer among males and the eleve...
AbstractIn order to determine the prognostic impact of lymphovascular invasion (LVI) in patients aft...
Whether lymphovascular invasion (LVI) is an independent prognostic factor in prostate cancer is stil...
To validate the impact of lymphovascular invasion (LVI) on biochemical recurrence (BCR) in patients ...
To systematically evaluate the prognostic value of lymphovascular invasion (LVI) in radical prostate...
Purpose: We tried to determine the clinicopathological significance of lymphovascular invasion (LVI)...
To assess the impact of lymphovascular invasion (LVI) on the risk of biochemical recurrence (BCR) in...
To assess the impact of lymphovascular invasion (LVI) on the risk of biochemical recurrence (BCR) in...
Abstract Background The association between lymphovascular invasion and lymphatic or hematogenous me...
Abstract: Objectives: To investigate relationship between the lymphovascular invasion(LVI) and tumor...
BACKGROUND: Recently, more detailed histopathological variables such as perineural invasion (PNI), l...
Objective Prostate cancer with seminal vesicle invasion (SVI) has been considered an aggressive can...
BACKGROUND/AIM: The lymphatic system plays an active role in the metastatic process by directly fac...
Aim To determine the impact of the extent of lymph node invasion (LNI) on long-term oncological out...
This paper, based on the activity of the Morphology-Based Prognostic Factors Committee of the 2004 W...
BACKGROUND: Bladder cancer is the fourth most frequently diagnosed cancer among males and the eleve...
AbstractIn order to determine the prognostic impact of lymphovascular invasion (LVI) in patients aft...
Whether lymphovascular invasion (LVI) is an independent prognostic factor in prostate cancer is stil...
To validate the impact of lymphovascular invasion (LVI) on biochemical recurrence (BCR) in patients ...
To systematically evaluate the prognostic value of lymphovascular invasion (LVI) in radical prostate...
Purpose: We tried to determine the clinicopathological significance of lymphovascular invasion (LVI)...
To assess the impact of lymphovascular invasion (LVI) on the risk of biochemical recurrence (BCR) in...
To assess the impact of lymphovascular invasion (LVI) on the risk of biochemical recurrence (BCR) in...
Abstract Background The association between lymphovascular invasion and lymphatic or hematogenous me...
Abstract: Objectives: To investigate relationship between the lymphovascular invasion(LVI) and tumor...
BACKGROUND: Recently, more detailed histopathological variables such as perineural invasion (PNI), l...
Objective Prostate cancer with seminal vesicle invasion (SVI) has been considered an aggressive can...
BACKGROUND/AIM: The lymphatic system plays an active role in the metastatic process by directly fac...
Aim To determine the impact of the extent of lymph node invasion (LNI) on long-term oncological out...
This paper, based on the activity of the Morphology-Based Prognostic Factors Committee of the 2004 W...
BACKGROUND: Bladder cancer is the fourth most frequently diagnosed cancer among males and the eleve...